187 related articles for article (PubMed ID: 2576354)
1. Antiallergic activity of picumast dihydrochloride in several animal species.
Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
Sekardi L; Friedberg KD
Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
[TBL] [Abstract][Full Text] [Related]
3. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
Wilhelms OH; Roesch A; Schaumann W
Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
[TBL] [Abstract][Full Text] [Related]
4. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep.
Abraham WM
Arzneimittelforschung; 1989 Oct; 39(10A):1328-31. PubMed ID: 2576357
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
Besenfelder E; Neubert P; Roesch A; Schaumann W; Wilhelms OH
Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
[TBL] [Abstract][Full Text] [Related]
6. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
Zimmermann I; Roesch A; Ulmer WT
Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
Schaumann W; Besenfelder E; Boehm E; Neubert P; Roesch A; Sterz H
Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356
[TBL] [Abstract][Full Text] [Related]
8. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
Wittenbrink-Dix AM; Neugebauer G; Fuhr U; Neubert P; Besenfelder E; Woelke-Seidl E; Harder S; Staib AH
Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
[TBL] [Abstract][Full Text] [Related]
9. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
Slapke J; Müller S; Boerner D
Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
[TBL] [Abstract][Full Text] [Related]
10. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
11. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
[TBL] [Abstract][Full Text] [Related]
12. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients.
Boerner D; Metz K; Eberhardt R
Arzneimittelforschung; 1989 Oct; 39(10A):1363-7. PubMed ID: 2576365
[TBL] [Abstract][Full Text] [Related]
14. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
15. [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine maleate, desonide and disodium cromoglycate after cutaneous administration].
Tarayre JP; Aliaga M; Villanova G; Barbara M; Bru M; Caillol V; Lauressergues H
J Pharmacol; 1984; 15(1):37-51. PubMed ID: 6425568
[TBL] [Abstract][Full Text] [Related]
16. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
17. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis of picumast dihydrochloride.
Witte EC
Arzneimittelforschung; 1989 Oct; 39(10A):1309. PubMed ID: 2576353
[TBL] [Abstract][Full Text] [Related]
20. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
